Media

Anesiva To Present At C.E. Unterberg, Towbin Emerging Growth Conference On July 12, 2006

SOUTH SAN FRANCISCO, CA, July 6, 2006 - Anesiva, Inc. (Nasdaq: ANSV) today announced that John P. McLaughlin, the company's chief executive officer, will present at the C.E. Unterberg, Towbin Emerging Growth Conference on July 12, 2006 at 2:50 p.m. EDT in New York City.

To access the live webcasts or the subsequent archived recordings, log on to www.anesiva.com and go to the Investors page, and click on Events. Please connect to Anesiva's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Anesiva

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has four drug candidates in clinical development for multiple potential indications, the most advanced of which, 3268, has completed Phase 3 clinical trials. Anesiva is based in South San Francisco, CA. For more information about Anesiva's leadership in the development of products for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to: www.anesiva.com.

Contact:
Jennifer Cook Williams
Vice President, Investor Relations
650-624-9600
[email protected]